252 related articles for article (PubMed ID: 7651731)
1. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.
Sanchez-Prieto R; Lleonart M; Ramón y Cajal S
Oncogene; 1995 Aug; 11(4):675-82. PubMed ID: 7651731
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1A gene.
Sánchez-Prieto R; Quintanilla M; Cano A; Leonart ML; Martin P; Anaya A; Ramón y Cajal S
Oncogene; 1996 Sep; 13(5):1083-92. PubMed ID: 8806698
[TBL] [Abstract][Full Text] [Related]
3. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanism.
Brader KR; Wolf JK; Hung MC; Yu D; Crispens MA; van Golen KL; Price JE
Clin Cancer Res; 1997 Nov; 3(11):2017-24. PubMed ID: 9815592
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
Somasundaram K; El-Deiry WS
Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
[TBL] [Abstract][Full Text] [Related]
6. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation.
Liu Y; McKalip A; Herman B
J Cell Biochem; 2000 May; 78(2):334-49. PubMed ID: 10842327
[TBL] [Abstract][Full Text] [Related]
8. The adenovirus E1A domains required for induction of DNA rereplication in G2/M arrested cells coincide with those required for apoptosis.
Yageta M; Tsunoda H; Yamanaka T; Nakajima T; Tomooka Y; Tsuchida N; Oda K
Oncogene; 1999 Aug; 18(34):4767-76. PubMed ID: 10490810
[TBL] [Abstract][Full Text] [Related]
9. Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation.
Bristow RG; Hu Q; Jang A; Chung S; Peacock J; Benchimol S; Hill R
Oncogene; 1998 Apr; 16(14):1789-802. PubMed ID: 9583677
[TBL] [Abstract][Full Text] [Related]
10. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
11. Mutant p53 protein expression interferes with p53-independent apoptotic pathways.
Li R; Sutphin PD; Schwartz D; Matas D; Almog N; Wolkowicz R; Goldfinger N; Pei H; Prokocimer M; Rotter V
Oncogene; 1998 Jun; 16(25):3269-77. PubMed ID: 9681825
[TBL] [Abstract][Full Text] [Related]
12. In vivo antitumor effect of retrovirus-mediated gene transfer of the adenovirus E1a gene.
Sánchez-Prieto R; Quintanilla M; Martín P; Lleonart M; Cano A; Dotto GP; Ramón y Cajal S
Cancer Gene Ther; 1998; 5(4):215-24. PubMed ID: 9694073
[TBL] [Abstract][Full Text] [Related]
13. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
Takimoto R; El-Deiry WS
Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms.
Teodoro JG; Shore GC; Branton PE
Oncogene; 1995 Aug; 11(3):467-74. PubMed ID: 7630630
[TBL] [Abstract][Full Text] [Related]
15. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
Fan S; Smith ML; Rivet DJ; Duba D; Zhan Q; Kohn KW; Fornace AJ; O'Connor PM
Cancer Res; 1995 Apr; 55(8):1649-54. PubMed ID: 7712469
[TBL] [Abstract][Full Text] [Related]
16. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
Li PX; Ngo D; Brade AM; Klamut HJ
Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
[TBL] [Abstract][Full Text] [Related]
17. Ultraviolet B-radiation dose influences the induction of apoptosis and p53 in human keratinocytes.
Cotton J; Spandau DF
Radiat Res; 1997 Feb; 147(2):148-55. PubMed ID: 9008206
[TBL] [Abstract][Full Text] [Related]
18. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
Chang FL; Ling YF; Lai MD
Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by tamoxifen-activation of a p53-estrogen receptor fusion protein expressed in E1A and T24 H-ras transformed p53-/- mouse embryo fibroblasts.
Vater CA; Bartle LM; Dionne CA; Littlewood TD; Goldmacher VS
Oncogene; 1996 Aug; 13(4):739-48. PubMed ID: 8761295
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene.
Guan B; Yue P; Clayman GL; Sun SY
J Cell Physiol; 2001 Jul; 188(1):98-105. PubMed ID: 11382926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
